Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:15 pm Purchase | 2024-12-31 | 13G | enGene Holdings Inc. Common Stock ENGN | Venrock Healthcare Capital Partners III, L.P. | 5,046,414 9.900% | 1,480,573 (+41.52%) | Filing History |
| 2025-02-14 5:16 pm Purchase | 2024-12-31 | 13G | enGene Holdings Inc. Common Stock ENGN | Kynam Capital Management LP | 4,994,090 9.800% | 4,994,090 (New Position) | Filing History |
| 2025-02-14 2:25 pm Sale | 2024-09-30 | 13G | enGene Holdings Inc. Common Stock ENGN | Foresite Capital Fund VI, L.P. | 0 0.000% | -2,500,000 (Position Closed) | Filing History |
| 2025-02-14 08:46 am Purchase | 2024-12-31 | 13G | enGene Holdings Inc. Common Stock ENGN | Deep Track Capital LP | 4,557,575 8.940% | 2,307,575 (+102.56%) | Filing History |
| 2025-02-12 09:35 am Sale | 2024-12-31 | 13G | enGene Holdings Inc. Common Stock ENGN | Adage Capital Management L.P. | 1,528,768 3.000% | -801,000 (-34.38%) | Filing History |
| 2025-01-29 5:12 pm Sale | 2025-01-27 | 13G | enGene Holdings Inc. Common Stock ENGN | BIOTECHNOLOGY VALUE FUND L P | 945,402 1.800% | -2,106,037 (-69.02%) | Filing History |
| 2025-01-29 5:09 pm Sale | 2024-12-31 | 13G | enGene Holdings Inc. Common Stock ENGN | BIOTECHNOLOGY VALUE FUND L P | 3,051,439 5.900% | -145,000 (-4.54%) | Filing History |
| 2024-11-14 5:48 pm Purchase | 2024-09-30 | 13G | enGene Holdings Inc. Common Stock ENGN | Venrock Healthcare Capital Partners III, L.P. | 3,565,841 8.100% | 1,000,000 (+38.97%) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | enGene Holdings Inc. Common Stock ENGN | Blue Owl Capital Holdings LP | 3,095,069 7.000% | 1,860,309 (+150.66%) | Filing History |
| 2024-11-14 07:53 am Sale | 2024-09-30 | 13G | enGene Holdings Inc. Common Stock ENGN | Omega Fund VII L.P. | 1,397,859 3.100% | -208,393 (-12.97%) | Filing History |
| 2024-11-12 09:30 am Purchase | 2024-09-30 | 13G | enGene Holdings Inc. Common Stock ENGN | Adage Capital Management L.P. | 2,329,768 5.270% | 2,329,768 (New Position) | Filing History |
| 2024-11-01 4:04 pm Purchase | 2024-10-30 | 13D | enGene Holdings Inc. Common Stock ENGN | Forbion Growth Sponsor FEAC I B.V. | 9,201,434 17.200% | 561,797 (+6.50%) | Filing History |
| 2024-10-21 12:35 pm Sale | 2024-09-30 | 13G | enGene Holdings Inc. Common Stock ENGN | Fonds de solidarite des travailleurs et des travailleuses du Quebec | 2,029,751 4.500% | -1,058,931 (-34.28%) | Filing History |
| 2024-10-18 4:15 pm Purchase | 2024-09-27 | 13D | enGene Holdings Inc. Common Stock ENGN | Forbion Growth Sponsor FEAC I B.V. | 8,639,637 18.500% | 470,633 (+5.76%) | Filing History |
| 2024-02-26 4:15 pm Purchase | 2024-02-16 | 13G | enGene Holdings Inc. Common Stock ENGN | Venrock Healthcare Capital Partners III, L.P. | 2,565,841 5.900% | 2,565,841 (New Position) | Filing History |
| 2024-02-23 4:48 pm Purchase | 2024-02-14 | 13G | enGene Holdings Inc. Common Stock ENGN | Deep Track Capital LP | 2,250,000 5.210% | 2,250,000 (New Position) | Filing History |
| 2024-02-23 1:32 pm Purchase | 2024-02-16 | 13G | enGene Holdings Inc. Common Stock ENGN | Foresite Capital Fund VI, L.P. | 2,500,000 5.800% | 2,500,000 (New Position) | Filing History |
| 2024-02-22 4:45 pm Unchanged | 2024-02-20 | 13G | enGene Holdings Inc. Common Stock ENGN | BIOTECHNOLOGY VALUE FUND L P | 3,196,439 7.200% | 0 (Unchanged) | Filing History |
| 2024-02-21 4:15 pm Purchase | 2024-02-20 | 13D | enGene Holdings Inc. Common Stock ENGN | Lumira Capital Investment Management Inc. | 4,181,853 9.600% | 800,000 (+23.66%) | Filing History |
| 2024-02-14 9:06 pm Purchase | 2023-12-31 | 13G | enGene Holdings Inc. Common Stock ENGN | Blue Owl Capital Holdings LP | 1,234,760 5.320% | 1,234,760 (New Position) | Filing History |